BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 31748894)

  • 1. Regulating the bioactivity of non-glycosylated recombinant human bone morphogenetic protein-2 to enhance bone regeneration.
    Yu Y; Chen R; Chen X; Wang J; Liu C
    Bioact Mater; 2024 Aug; 38():169-180. PubMed ID: 38711759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Escherichia coli-derived Recombinant Human Bone Morphogenic Protein-2 on Fertilization and Early Embryonic Development in Rats.
    Kim NH; Min SK; Lee MW; Kang SH
    Pharm Res; 2023 Jun; 40(6):1569-1576. PubMed ID: 37081303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate-Affinity Affibodies Modulate the Delivery and Bioactivity of Bone Morphogenetic Protein-2.
    Dorogin J; Hochstatter HB; Shepherd SO; Svendsen JE; Benz MA; Powers AC; Fear KM; Townsend JM; Prell JS; Hosseinzadeh P; Hettiaratchi MH
    Adv Healthc Mater; 2023 Oct; 12(26):e2300793. PubMed ID: 37379021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of the Topmost Layer and the Type of Bone Morphogenetic Protein-2 Immobilization on the Mesenchymal Stem Cell Response.
    Wytrwal-Sarna M; Sekuła-Stryjewska M; Pomorska A; Ocłoń E; Gajos K; Sarna M; Zuba-Surma E; Bernasik A; Szczubiałka K
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Human Bone Morphogenetic Protein-2 (hBMP-2) in
    Oliveira JE; Suzuki MF; Damiani R; Lima ER; Amaral KC; Santos AMS; Magalhães GS; Faverani LP; Pereira LAVD; Bartolini P
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA- and Activity Assay-Based Quantification of BMP-2 Released
    Sundermann J; Sydow S; Burmeister L; Hoffmann A; Menzel H; Bunjes H
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33921903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Morphogenetic Protein 2 (BMP-2) Aggregates Can be Solubilized by Albumin-Investigation of BMP-2 Aggregation by Light Scattering and Electrophoresis.
    Sundermann J; Zagst H; Kuntsche J; Wätzig H; Bunjes H
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile for the clinical use of bone morphogenetic proteins in the spine.
    Poynton AR; Lane JM
    Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S40-8. PubMed ID: 12205419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and Biological Activity of E. coli Derived Soluble and Precipitated Bone Morphogenetic Protein-2.
    Quaas B; Burmeister L; Li Z; Satalov A; Behrens P; Hoffmann A; Rinas U
    Pharm Res; 2019 Nov; 36(12):184. PubMed ID: 31748894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Luca L; Capelle MA; Machaidze G; Arvinte T; Jordan O; Gurny R
    Int J Pharm; 2010 May; 391(1-2):48-54. PubMed ID: 20156542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble expression and purification of high-bioactivity recombinant human bone morphogenetic protein-2 by codon optimisation in Escherichia coli.
    Chen W; Zhang C; Wu Y; Su X
    Protein Eng Des Sel; 2019 Dec; 32(3):153-157. PubMed ID: 31603219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.
    Vallejo LF; Brokelmann M; Marten S; Trappe S; Cabrera-Crespo J; Hoffmann A; Gross G; Weich HA; Rinas U
    J Biotechnol; 2002 Mar; 94(2):185-94. PubMed ID: 11796171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium modification up-regulates the bioactivity of bone morphogenetic protein-2 upon calcium phosphate cement via enhanced BMP receptor recognition and Smad signaling pathway.
    Ding S; Zhang J; Tian Y; Huang B; Yuan Y; Liu C
    Colloids Surf B Biointerfaces; 2016 Sep; 145():140-151. PubMed ID: 27156155
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.